80 likes | 179 Views
The role of stakeholders in EU policy making EAMBES contribution to BME in EU. Leire Solis Rohde Public Policy. Background. Background: Created in 2002 by Sebastian Rohde
E N D
The role of stakeholders in EU policy makingEAMBES contribution to BME in EU Leire Solis Rohde Public Policy
Background • Background: • Created in 2002 by Sebastian Rohde • Reason: Create new approach for policy development in health policy by including all relevant stakeholders at all stages of policy making at EU level • Objective: Development and positioning of health and research topics at political level based on expert opinion and political reason • Means: Development of long-term partnerships with policy makers, high-level scientists and other stakeholders • Areas of expertise: healthcare and healthcare/related areas (patient access to therapies, research and innovation, social policy, nutrition, disabilities, demography, market access, etc)
How we understand “policy development” Objective: Support development of policy based on consensus and working for an improved regulatory and political environment supporting better health • Establishing political and scientific consensus • With all parties affected, including policy makers, high-level scientists and other stakeholders • Encouraging our partners to extend their work to involve other non commercial partners such as patient groups, research and medical experts
Importance of external opinion for policy making Objective: building long-term consensus and partnerships among different stakeholders, policy makers and the scientific community. • Creating new and sustainable alliances sharing similar objectives • Building working relationships based on expertise • Bringing added-value and second opinions to the policy-making process
Health policy = Societal policy Every health topic has a great societal effect Employment, Economics, Demography, etc. Societal interests need to be reflected Example: Hepatitis B • Appears to be an infection BUT • It actually includes: • Health & safety at work • Migration • Civil liberties Sustainable policy is limited if these groups are not included in the development of policy
BME in EU policies • Consolidation in different policies: • To improve health • To foster innovative research • To develop a new sector with great potential for innovation • Totacklesocietalchallenges • BME is now understood as being part of various fields BUT with a supportive legislation it will develop into a recognised innovative sector on its own right • Example of Biotech policy and biotech sector: • Early 1990s: research sector part of food, plants, chemicals, health • Biotech became a sector in its own right with ability to develop into specific field of policy and societal value • Horizontal (Biotech patents Directive) and vertical (OMP Regulation) policies supported creation for better health, economic growth and innovation in Europe
EAMBES contribution to BME promotion in EU policies • Currently: Value of innovation understood by EU policy makers • Need: concrete examplesfrominvolvedactors in policyimplementation EAMBESaddedvalue: • Onlyrepresentation of BME at EU level • Onevoiceforapprox 8000 EuropeanexpertsonBME EAMBEScontribution: • Sharingexpertise and knowledgewith EU decisionmakers and stakeholders (i.e.publicconsultations) • Workingrelationshipwithrelevant EU policymakers (EuropeanCommission, EuropeanParliament) • Development of policyforumfordiscussion of EU policy